In
China, the
survival rate of
liver cancer remains low while the mortality rate is high. Effectively reducing the burden of
liver cancer is still a major challenge in the field of
public health and
chronic disease prevention in the
Chinese population. Optimizing
screening strategies for
liver cancer remains a profound approach to
secondary prevention worthy of continuous explora-tion. This
guideline was commissioned by the Bureau of
Disease Control and Prevention of the National
Health Commission. The National
Cancer Center of
China initiated the
guideline develop-ment and convened a multidisciplinary expert panel and working group. Following the
World Health Organization Handbook for
Guideline Development, this
guideline integrated the most up-to-date evidence of
liver cancer screening,
China′s national conditions, and existing practical experience in
liver cancer screening. Evidence-based recommendations on the
target population,
screening technologies,
surveillance strategies, and other key points across the process of
liver cancer screening and
surveillance management were provided. This
guideline would help to standardize the practice of
liver cancer screening in
China.